A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation

Journal of Clinical Investigation

Volumn 114, Issue 6, 2004, Pages 857-866

  Sugimoto, Kenji ^a   Ohata, Mutsuhiro ^a   Miyoshi, Jun ^b   Ishizaki, Hiroyoshi ^b,c   Tsuboi, Naotake ^a   Masuda, Akio ^a   Yoshikai, Yasunobu ^d   Takamoto, Masaya ^e   Sugane, Kazuo ^e   Matsuo, Seiichi ^a   Shimada, Yasuhiro ^a   Matsuguchi, Tetsuya ^f  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c KAN Research Institute ^*  (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 12 PROMOTER BINDING PROTEIN; MESSENGER RNA; OVALBUMIN; PROTEIN COT; PROTEIN SERINE THREONINE KINASE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CYTOKINE PRODUCTION; ENZYME ACTIVITY; LEISHMANIA MAJOR; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPRESSOR GENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 9644301015     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI20014     Document Type: Article

References (48)

1. Aderem, A., and Underbill, D.M. 1999. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17:593-623.
2. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol 1:135-145.
3. Trinchieri, G. 1995. Interleukin-12: a pro-inflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
4. Macatonia, S.E., et al. 1995. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol. 154:5071-5079.
5. Akira, S., Takeda, K., and Kaisho, T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-680.
6. Higashi, T, et al. 1990. Hamster cell line suitable for transfection assay of transforming genes. Proc. Natl. Acad. Sci. U. S. A. 87:2409-2413.
7. Miyoshi, J., Higashi, T., Mukai, H., Ohuchi, T., and Kakunaga, T. 1991. Structure and transforming potential of the human cot oncogene encoding a putative protein kinase. Mol. Cell. Biol. 11:4088-4096.
8. Erny, K.M., Peli, J., Lambert, J.F., Muller, V., and Diggelmann, H. 1996. Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis. Oncogene. 13:2015-2020.
9. Ceci, J.D., et al. 1997. Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation. Genes Dev. 11:688-700.
10. Salmeron, A., et al. 1996. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J. 15:817-826.
11. Chiariello, M., Marinissen, M.J., and Gutkind,J.S. 2000. Multiple mitogen-activaced protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation. Mol. Cell. Biol. 20:1747-1758.
12. Tsatsanis, C., Patriotis, C., and Tsichlis, P.N. 1998. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB. Oncogene. 17:2609-2618.
13. Belich, M.P., Salmeron, A., Johnston, L.H., and Ley, S.C. 1999. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105. Nature. 397:363-368.
14. Lin, X., Cunningham, E.T., Jr., Mu, Y., Geleziunas, R., and Greene, W.C. 1999. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases. Immunity. 10:271-280.
15. Beinke, S., et al. 2003. NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity. Mol. Cell. Biol. 23:4739-4752.
16. Waterfield, M.R., Zhang, M., Norman, L.P., and Sun, S.C. 2003. NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. Mol. Cell. 11:685-694.
17. Dumitru, C.D., et al. 2000. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell. 103:1071-1083.
18. Eliopoulos, A.G., Dumitru, C.D., Wang, C.C., Cho, J., and Tsichlis, P.N. 2002. Induction of COX-2 by LPS in macrophages is regulated byTpl2-dependent CREB activation signals. EMBO J. 21:4831-4840.
19. Eliopoulos, A.G., Wang, C.C., Dumitru, C.D., and Tsichlis, P.N. 2003. Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40. EMBO J. 22:3855-3864.
20. Lu, H.T., et al. 1999. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 18:1845-1857.
21. Becker, C., et al. 2001. Regulation of IL-12 p40 promoter activity in primary human monocytes: roles of NF-kappaB, CCAAT/enhancer-binding protein beta, and PU.1 and identification of a novel repressor element (GA-12) that responds to IL-4 and prostaglandin E(2). J. Immunol. 167:2608-2618.
22. Cao, S., et al. 2002. Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma. J. Immunol. 169:5715-5725.
23. Kawai, T., Adachi, O., Ogawa, T., Takeda, K., and Akira, S. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:115-122.
24. Doyle, S., et al. 2002. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 17:251-263.
25. Yamamoto, M., et al. 2002. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature. 420:324-329.
26. Ahmad-Nejad, P., et al. 2002. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32:1958-1968.
27. Hacker, H., et al. 1998. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17:6230-6240.
28. Monick, M.M., Carter, A.B., Flaherty, D.M., Peterson, M.W., and Hunninghake, G.W. 2000. Protein kinase C zeta plays a central role in activation of the p42/44 mitogen-activated protein kinase by endotoxin in alveolar macrophages. J. Immunol. 165:4632-4639.
29. Aksoy, E., Amraoui, Z., Goriely, S., Goldman, M., and Willems, F. 2002. Critical role of protein kinase C epsilon for lipopolysaccharide-induced IL-12 synthesis in monocyte-derived dendritic cells. Eur. J. Immunol. 32:3040-3049.
30. van der Bruggen, T., Nijenhuis, S., van Raaij, E., Verhoef, J., and van Asbeck, B.S. 1999. Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infect. Immun. 67:3824-3829.
31. Rutault, K., Hazzalin, C.A., and Mahadevan, L.C. 2001. Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha) mRNA induction. Evidence for selective destabilization of TNF-alpha transcripts. J. Biol. Chem. 276:6666-6674.
32. Kuhn, R., Lohler J., Rennick, D., Rajewsky, K., and Muller, W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:263-274.
33. Hacker, H., et al. 1999. Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-present ing cells. EMBO J. 18:6973-6982.
34. Hosken, N.A., Shibuya, K., Heath, A.W., Murphy, K.M., and O'Garra, A. 1995. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J. Exp. Med. 182:1579-1584.
35. Constant, S., Pfeiffer, C., Woodard, A., Pasqualini, T., and Bottomly, K. 1995. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J. Exp. Med. 182:1591-1596.
36. DiMolfetto, L., Neal, H.A., Wu, A., Reilly, C., and Lo, D. 1998. The density of the class II MHC T cell receptor ligand influences IFN-gamma/IL-4 ratios in immune responses in vivo. Cell. Immunol. 183:70-79.
37. Stavnezer, J. 1996. Antibody class switching. Adv. Immunol. 61:79-146.
38. Manis, J.P., Tian, M., and Alt, F.W. 2002. Mechanism and control of class-switch recombination. Trends Immunol. 23:31-39.
39. Stoll, S., et al. 1998. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur. J. Immunol. 28:3231-3239.
40. de Saint-Vis, B., et al. 1998. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J. Immunol. 160:1666-1676.
41. de Veer, M.J., et al. 2003. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur. J. Immunol. 33:2822-2831.
42. Muraille, E., et al. 2003. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J. Immunol. 170:4237-4241.
43. Brown, W.C., Estes, D.M., Chantler, S.E., Kegerreis, K.A., and Suarez, C.E. 1998. DNA and a CpG oligonucleotide derived from Babesia bovisare mitogenic for bovine B cells. Infect. Immun. 66:5423-5432.
44. Kanaly, S.T., Nashleanas, M., Hondowicz, B., and Scott, P. 1999. TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens. J. Immunol. 163:3883-3889.
45. Wilhelm, P., et al. 2001. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J. Immunol. 166:4012-4019.
46. Koera, K., et al. 1997. K-ras is essential for the development of the mouse embryo. Oncogens. 15:1151-1159.
47. Matsuguchi, T., Musikacharoen, T., Johnson, T.R., Kraft, A.S., and Yoshikai, Y. 2001. A novel mitogen-activated protein kinase phosphatase is an important negative regulator of lipopolysaccharide-mediated c-Jun N-terminal kinase activation in mouse macrophage cell lines. Mol. Cell. Biol. 21:6999-7009.
48. Matsuguchi, T., Takagi, K., Musikacharoen, T., and Yoshikai, Y. 2000. Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes. Blood. 95:1378-1385.